ArticlePloS one2015

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.

Estelle Daudigeos-Dubus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.